(Q34222754)

English

Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

W Ross Tracey

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

William P Magee

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Joseph J Oleynek

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Roger J Hill

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Andrew H Smith

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

David M Flynn

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Delvin R Knight

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

14 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

285

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

H2780-7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

A novel cardioprotective role of RhoA: new signaling mechanism for adenosine

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Adenosine, adenosine receptors and myocardial protection: an updated overview

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning?

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00411.2003

21 January 2018

Identifiers

10.1152/AJPHEART.00411.2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34222754&oldid=1964352057"